ZA839451B - A composition for use in a method for alleviation of extrapyramidal motor disorders - Google Patents

A composition for use in a method for alleviation of extrapyramidal motor disorders

Info

Publication number
ZA839451B
ZA839451B ZA839451A ZA839451A ZA839451B ZA 839451 B ZA839451 B ZA 839451B ZA 839451 A ZA839451 A ZA 839451A ZA 839451 A ZA839451 A ZA 839451A ZA 839451 B ZA839451 B ZA 839451B
Authority
ZA
South Africa
Prior art keywords
alleviation
composition
motor disorders
extrapyramidal motor
extrapyramidal
Prior art date
Application number
ZA839451A
Other languages
English (en)
Inventor
Lloyd E Allen
Leslie A Riblet
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA839451B publication Critical patent/ZA839451B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA839451A 1982-12-23 1983-12-20 A composition for use in a method for alleviation of extrapyramidal motor disorders ZA839451B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/452,686 US4438119A (en) 1982-12-23 1982-12-23 Method for alleviation of extrapyramidal motor disorders

Publications (1)

Publication Number Publication Date
ZA839451B true ZA839451B (en) 1984-09-26

Family

ID=23797489

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA839451A ZA839451B (en) 1982-12-23 1983-12-20 A composition for use in a method for alleviation of extrapyramidal motor disorders

Country Status (7)

Country Link
US (1) US4438119A (enExample)
JP (1) JPS59130215A (enExample)
AU (1) AU556112B2 (enExample)
BE (1) BE898540A (enExample)
DE (1) DE3346237A1 (enExample)
PH (1) PH18968A (enExample)
ZA (1) ZA839451B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634703A (en) * 1985-10-25 1987-01-06 Bristol-Myers Company Method for alleviation of panic disorders
US4640921A (en) * 1986-02-04 1987-02-03 Bristol-Myers Treatment of sexual dysfunction with buspirone
US4687772A (en) * 1986-10-07 1987-08-18 Bristol-Myers Company Method for improvement of short term memory
US4777173A (en) * 1987-03-25 1988-10-11 Bristol-Myers Company Method for treatment of alcohol abuse
DE3736974A1 (de) * 1987-10-31 1989-05-11 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
US5468749A (en) * 1988-08-30 1995-11-21 Gawin; Frank H. Method for treatment of substance addiction
US6432956B1 (en) 1990-02-12 2002-08-13 William C. Dement Method for treatment of sleep apneas
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5824680A (en) * 1991-08-31 1998-10-20 Bayer Aktiengesellschaft Ipsapirone for the treatment of alzheimer's disease by improving memory
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
EP1408964B1 (en) * 2001-07-26 2007-01-24 MERCK PATENT GmbH Use of 2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl|-chromane and its physiologically acceptable salts
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
GT200600414A (es) * 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
GT200600416A (es) * 2005-09-12 2007-09-20 Sales salicilato y gentisato de un compuesto de piperazina
PE20070523A1 (es) * 2005-09-12 2007-06-28 Wyeth Corp Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona
HRP20161402T1 (hr) * 2010-10-15 2016-12-30 Contera Pharma Aps Kombinacije agonista serotoninskih receptora za liječenje poremećaja kretanja
ES2654787T3 (es) 2012-04-18 2018-02-15 Contera Pharma Aps Formulación farmacéutica disponible por vía oral adecuada para la gestión mejorada de trastornos del movimiento
HUE039750T2 (hu) * 2014-06-26 2019-02-28 Contera Pharma Aps Hidroxi-buspiron mozgászavarok kezelésére
WO2018011181A1 (en) 2016-07-11 2018-01-18 Contera Pharma Aps Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method

Also Published As

Publication number Publication date
PH18968A (en) 1985-11-26
US4438119A (en) 1984-03-20
BE898540A (fr) 1984-06-22
AU556112B2 (en) 1986-10-23
JPH0422889B2 (enExample) 1992-04-20
DE3346237A1 (de) 1984-07-05
JPS59130215A (ja) 1984-07-26
AU2279383A (en) 1984-06-28

Similar Documents

Publication Publication Date Title
ZA839451B (en) A composition for use in a method for alleviation of extrapyramidal motor disorders
GB2133325B (en) Apparatus for making tool
PH20679A (en) Method for stimulating salivation
GB2070667B (en) Well slotting tool and method
GB2128807B (en) Improvements in or relating to a method for fabricating an mos device
ZA824233B (en) Therapeutic method and method for making compositions for use therein
GB2074026B (en) Method and composition for reducing pain
HUT35234A (en) Process for preparing leucotriene antagonists
DE3371368D1 (en) Tool and method for its production
HUT42715A (en) Method for producing ion-exchanging compositions
GB8327239D0 (en) Tamping tool unit
DE3171583D1 (en) Tool for rotating threaded fasteners
GB2134576B (en) Tamping tool
EP0227192A3 (en) Method for determining the amount of oil in a sponge core
GB2132546B (en) Improvements in or relating to work stations
DE3476012D1 (en) Shrimp-peeling machine according to the method of van woensel
HUT34126A (en) Process for preparing interferone gel compositions
EP0135996A3 (en) Improvements in or relating to containers and methods of, and apparatus for, manufacturing containers
GB2130906B (en) Improvements in or relating to apparatus for dispensing a dust suspension
PL253144A1 (en) Whee-set reprofiling method
ZA843779B (en) Composition for treating asthma
JPS57165206A (en) Method of removing resin in resin bag
ZA835485B (en) Method for improving briquetting
GR81084B (en) Method for the preparation of azabicyclic
EP0090417A3 (en) Process for producing 3'-deoxyguanosine